Trial Profile
Trial to study the effect of denosumab for the treatment of patients with bone metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Denosumab (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 09 Jun 2016 New trial record